Only a small portion of patients can be helped with stem cell therapy
Most of the funds have been spent on building, not research
Paolo Macchiarini was one of the hottest names in science, but now dark clouds hang over his work
MIT Technology Review expresses some scepticism
Australia has seen a sharp rise in the use of unproven stem cell treatments.
Proof-of-concept clinical trials on 20 patients in India
Celebrity surgeon Paolo Macchiarini under fire in Sweden and the US
Many “cures” are problematic and unsustainable
A new paper claims that induced stem cells are functionally equivalent to embryonic stem cells
Australian Researchers have managed to grow a mini-kidney in a laboratory
Whatever happened to the mad cloners?
Regulators in the United States and Australia are examining the burgeoning field of stem cell therapies.
Shades of Hwang Woo-suk.
A noble goal, but there are too many unanswered questions.
A Portuguese stem-cell trial gone wrong has resulted in a woman developing a nasal growth on her back.
Nature has retracted a paper and a letter, both published in January, which claimed that physical perturbation of cells could create genetic effects.
Haruko Obokata reportedly has told co-authors on the paper on stimulus-triggered acquisition of pluripotency (STAP) cells that she was prepared to retract it.
The Icarus-like rise of Japanese stem cell research Haruko Obokata has ended with a gigantic splash.
The case of Davide Vannoni, head of the stem cell therapy company Stamina Foundation, is turning into an election issue.
Page 1 of 6 : 1 2 3 > Last ›